These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29106905)

  • 1. Characterisation of endogenous A
    Goulding J; May LT; Hill SJ
    Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
    Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capadenoson, a clinically trialed partial adenosine A
    Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The A
    Mølck C; Ryall J; Failla LM; Coates JL; Pascussi JM; Heath JK; Stewart G; Hollande F
    Cancer Lett; 2016 Dec; 383(1):135-143. PubMed ID: 27693637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
    Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT
    J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of adenosine A
    Carlin JL; Jain S; Duroux R; Suresh RR; Xiao C; Auchampach JA; Jacobson KA; Gavrilova O; Reitman ML
    Neuropharmacology; 2018 Sep; 139():268-278. PubMed ID: 29548686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regionally selective cardiovascular responses to adenosine A
    Cooper SL; Wragg ES; Pannucci P; Soave M; Hill SJ; Woolard J
    FASEB J; 2022 Apr; 36(4):e22214. PubMed ID: 35230706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
    Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
    Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSB 603 - a known selective adenosine A2B receptor antagonist - has anti-inflammatory activity in mice.
    Kotańska M; Szafarz M; Mika K; Dziubina A; Bednarski M; Müller CE; Sapa J; Kieć-Kononowicz K
    Biomed Pharmacother; 2021 Mar; 135():111164. PubMed ID: 33385856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tritium-labeled agonists as tools for studying adenosine A
    Hinz S; Alnouri WM; Pleiss U; Müller CE
    Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel curcumin analog (cis-trans curcumin) as ligand to adenosine receptors A
    Hamilton LJ; Walker M; Pattabiraman M; Zhong HA; Luedtke B; Chandra S
    Pharmacol Res; 2021 Mar; 165():105410. PubMed ID: 33401004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulators of human A2B adenosine receptor.
    Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
    Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric Antagonism of the A
    Gao ZG; Toti KS; Campbell R; Suresh RR; Yang H; Jacobson KA
    Cells; 2020 May; 9(5):. PubMed ID: 32408534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A
    De Filippo E; Hinz S; Pellizzari V; Deganutti G; El-Tayeb A; Navarro G; Franco R; Moro S; Schiedel AC; Müller CE
    Biochem Pharmacol; 2020 Feb; 172():113718. PubMed ID: 31751537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Ongini E; Dionisotti S; Gessi S; Irenius E; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):7-10. PubMed ID: 9933143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2A and A2B adenosine receptors.
    Conde SV; Obeso A; Vicario I; Rigual R; Rocher A; Gonzalez C
    J Neurochem; 2006 Jul; 98(2):616-28. PubMed ID: 16805851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Jiang J; Seel CJ; Temirak A; Namasivayam V; Arridu A; Schabikowski J; Baqi Y; Hinz S; Hockemeyer J; Müller CE
    J Med Chem; 2019 Apr; 62(8):4032-4055. PubMed ID: 30835463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts.
    Xi J; McIntosh R; Shen X; Lee S; Chanoit G; Criswell H; Zvara DA; Xu Z
    J Mol Cell Cardiol; 2009 Nov; 47(5):684-90. PubMed ID: 19695259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells.
    Cooper J; Hill SJ; Alexander SP
    Br J Pharmacol; 1997 Oct; 122(3):546-50. PubMed ID: 9351513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.